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Abstract
Background: Often, multiple measures of a trait are available in a genetic linkage analysis. We
compare Monte Carlo Markov chain analysis of two very different measures of hypertension in the
simulated Genetic Analysis Workshop 13 data to examine how choice of measure affects the
results. The measures selected were age-of-onset of hypertension and systolic blood pressure at
first visit.
Results: In combined segregation and linkage analysis of the complete pedigrees using the first
replicate of the simulated data with missing values, we found that the age-of-onset analysis was
better at identifying "slope" genes, while the systolic blood pressure analysis was better at
identifying "baseline" genes.
Conclusion: Analysis of different trait measures may identify different trait-related genes. When
linkage analysis is conducted on multiple trait measures, a linkage signal found for only one measure
can represent a true trait locus.
Background
In studies such as the Framingham Heart Study (e.g. [1])
or the Collaborative Study on the Genetics of Alcoholism
(COGA) [2], a number of different values related to a dis-
ease are measured, and the first step in the analysis may be
choosing one measure. The simulated data in Genetic
Analysis Workshop 13 (GAW13), for example, offered
many measures related to hypertension. Exactly which
measure one uses may depend on the analysis method,
heritability estimates, and clinical knowledge of the
mechanisms behind the disease. Sometimes more than
one measure is analyzed and different results are obtained
for the different measures, as was see in the GAW11 anal-
yses of the COGA data [3].
Here, we compared two different simulated measures of
hypertension in analyses with Monte Carlo Markov chain
(MCMC) oligogenic combined segregation and linkage
analysis, as implemented in the program Loki [4]. These
methods use linkage data on extended pedigrees and esti-
mate the number, location, and effects of loci that contrib-
ute to a quantitative trait. We chose two measures of a type
that might be collected in a retrospective study: age-of-
onset of hypertension (AOH) and systolic blood pressure
at the first visit (SBP). We made these choices with knowl-
edge of the generating model. We wanted to determine
whether these different measures would localize different
trait loci.
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Methods
Trait selection
From the first replicate of the simulated GAW13 data, we
selected two traits that were related, but had slightly differ-
ent genetic characteristics. Both simulated traits we
selected, AOH and SBP at the first visit, are related to
hypertension. However, since the generating model
divided the trait loci into those that affected "baseline"
value and those that affected "slope," we expected that
SBP would localize "baseline" genes, while AOH would
localize "slope" genes. For SBP we used the SBP value
from the first examination in both cohorts. We used the
simulated data with missing values. The data set did not
contain age-of-onset data as a separate value, but it did
contain an indicator of hypertension diagnosis at each
visit. We used the age at the earliest visit with a hyperten-
sion diagnosis as AOH. Since "baseline" was age 20 at the
generating model and the first visit occurred at different
ages for different subjects, our SBP measure was not a pure
measure of the "baseline." Similarly, since AOH was
determined by the crossing of a threshold, AOH is not a
pure measure of "slope." Such "impure" measures may,
however, better reflect the measures found in studies of
real data.
MCMC segregation and linkage analysis
To estimate the number, effects, and location of loci con-
tributing to AOH and SBP, we applied the MCMC segre-
gation and linkage analysis methods described in Heath
[4] and Daw et al. [5]. These methods also estimate cov-
ariate effects, and the trait model is given by
where µ is the "reference" trait value, X is the incidence
matrix for covariate effects, β is the vector of covariate
effects, Qi is the incidence matrix for the effects of QTL i,
αi is the vector of effects for QTL i, e is the normally dis-
tributed residual effect, and k is the number of QTL cur-
rently estimated (k ≥ 0). The MCMC process samples µ, β,
αi,  i, and e  as well as parameters such as unobserved
marker genotypes. All these parameters are sampled from
the space of model values consistent with the data
observed. Values are sampled proportional to their poste-
rior probability. After the number of sampling iterations
is sufficiently large, the sampled values provide an esti-
mate of the posterior probability distribution over the
space of possible parameter configurations. We chose a set
of covariates that had an effect in the generating model.
For comparability, nearly the same covariates were used
for both traits. For SBP, the covariates included cigarettes
smoked per day (CPD), sex, and age, as reported at the
first visit. For AOH, the effects of CPD and sex were esti-
mated as covariates. AOH covariates are a subset of those
for SBP, with only age not used in the case of AOH. The
censored trait model described in [5] was used for AOH.
This censoring model is essentially a genetic survival anal-
ysis with cumulative normal survival curves. Thus, the age
information still contributes in both of our analyses.
We conducted a complete genome scan for both traits. We
first carried out analyses on both models on all 22 chro-
mosomes using 50,000 iterations, while saving every fifth
iteration. On chromosomes with evidence for linkage, we
followed up with longer runs. Additionally, for each trait
we conducted a longer multi-chromosome analysis
including all chromosomes with an L score > 5. These
longer runs were 200,000 to 500,000 iterations in length.
All analyses were conducted with the sex-averaged Hal-
dane map provided with the simulated data.
Bayesian "L-score"
To evaluate evidence for linkage, we considered Bayes fac-
tors estimated over 1-cM wide bins along the chromo-
somes. A Bayes factor is simply the posterior probability
divided by the prior probability. In the absence of any
data, a Bayesian analysis should have posterior probabil-
ity equal to the prior probability. Thus, a Bayes factor of 1
indicates that the data contains no information for or
against linkage. A Bayes factor < 1 indicates evidence
against linkage, while a Bayes factor > 1 indicates evidence
for linkage. We refer to these Bayes factors for linkage cal-
culated in 1-cM intervals as "L-scores." We used the Hal-
dane map provided with the simulated data.
Results
In both analyses, there were three regions with L-scores
that stood out with values > 50, while the next largest
scores were < 25. All three regions that were identified in
this way contained simulated trait loci (see Table 1). As
expected, the largest L-score in the AOH analysis was at
the largest-effect "slope" gene, Gs10. The peak score
occurred in a bin adjacent to the one actually containing
the locus, so the localization of the gene was within 2 cM
of the true location. Also as expected, the largest L-score in
the SBP analysis was at the largest effect SBP baseline gene,
Gb34, although the peak was some 8 cM away from the
true gene location. The second largest "baseline" gene,
Gb35, was also identified in the SBP analysis. Of particu-
lar interest, the SBP analysis also identified Gs10,
although the L-score was somewhat smaller than the AOH
analysis, and the peak value was further from the true gene
location than in the AOH analysis. The AOH analysis
found weak evidence for linkage at Gb34 and no evidence
for linkage at Gb35.
Exactly where to draw a threshold for follow-up is not
clear. In addition to the three locations with L-scores > 50,
there were several regions with L-scores > 10 and < 50. For
completeness, we list all regions with L-scores > 10. For
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AOH, these L-scores were: ~21 at ~80 cM on chromosome
5, ~22 at ~95 cM on chromosome 7, ~15 at 45 cM on
chromosome 14, and ~11 at ~50 cM on chromosome 19.
For SBP, these L-scores were: ~14 at ~220 cM on chromo-
some 3 and ~11 at ~95 cM on chromosome 16. Since no
trait loci were placed on even-numbered chromosomes,
the two signals on even numbered chromosomes repre-
sent weak false-positives. It is more difficult to say any-
thing conclusive about the signals on the odd-numbered
chromosomes because of the complexity of the generating
model: all of the odd numbered chromosomes do, in fact,
contain loci that contribute to the simulated hypertension
trait. Since more signals in this range of 10 to ~20 are on
odd numbered chromosomes, it seems likely that at least
some of these are true weak positive signals. The largest
effect height gene, Gb1, is at ~80 cM on chromosome 5,
while a total of nine different genes are on chromosome
7, making these signals for AOH likely true weak positives
and both of these are over 20. Any threshold value may
depend on the investigators tolerance of false-positives,
but while the three strong signals (Table 1) were all > 50,
the next best signal was < 25, and the largest score on an
even-numbered chromosome was ~15.
Conclusions
We find that analysis of AOH is better at localizing slope
genes, while analysis of SBP is better at identifying base-
line genes. We noted with interest at GAW 13 that some
other groups reported better localization of slope genes
with methods that examine value at one time-point rather
than "slope." We believe we were able to identify Gs10 in
our SBP analysis because most subjects were over the base-
line age of 20 at the first visit and the slopes were generally
positive, causing the variation in SBP to increase with age.
Some alternate generating models were suggested at the
GAW 13 meeting under which we would expect our SBP
analysis to fail to localize slope loci. Exactly what cut-off
should be used for declaring significance with L-scores
remains an open question. Our results suggest that analy-
sis of different trait measures can identify different trait
loci. Thus, if one has multiple measures, conducts linkage
analyses on all of them, and only focuses on those linkage
signals replicated in analyses of several measures, one may
miss some trait loci.
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Table 1: Locations of largest L-scores in single chromosome analysis of AOH and SBPA
AOHB SBP
QTL Location L-score Peak L-score Peak
Gs10 53.59 cM – chr. 21 94.5 52 cM 76.7 49 cM
Gb34 176.08 cM – chr. 5 4.8 180 cM 84.4 168 cM
Gb35 85.16 cM – chr. 13 0.3 93 cM 59.4 94 cM
AValues and peak locations for largest L-scores. BL-score values for AOH analysis at Gb34 and Gb35 included for comparison.